Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07446608

MRI-Based Prediction of Dienogest Response in Endometriosis

Predicting the Efficacy of Dienogest in Patients With Endometriosis Using MRI

Status
Recruiting
Phase
Study type
Observational
Enrollment
48 (estimated)
Sponsor
Chungnam National University Sejong Hospital · Academic / Other
Sex
Female
Age
19 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The goal of this prospective observational study is to learn whether magnetic resonance imaging (MRI) findings can help predict treatment response to dienogest in women with endometriosis. Endometriosis is a common gynecologic condition that can cause chronic pelvic pain and negatively affect quality of life. Although dienogest is widely used as a standard medical treatment, individual responses to treatment vary. The main questions this study aims to answer are: * Whether baseline MRI characteristics of endometriotic lesions are associated with improvement in pelvic pain after dienogest treatment. * Whether MRI findings can help identify patients who are more likely to benefit from dienogest therapy. Participants diagnosed with endometriosis who are prescribed dienogest as part of their routine clinical care will be enrolled. This study does not assign any investigational intervention. Participants will undergo standard clinical follow-up, including pelvic pain assessment using visual analog scale (VAS) scores, quality of life questionnaires, and routine MRI examinations. Clinical and imaging data will be collected prospectively and analyzed to explore imaging predictors of treatment response.

Conditions

Timeline

Start date
2025-10-14
Primary completion
2027-03-01
Completion
2027-03-01
First posted
2026-03-03
Last updated
2026-03-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07446608. Inclusion in this directory is not an endorsement.